Accès libre

Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients

À propos de cet article

Citez

Martina Rebersek
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Tanja Mesti
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Marko Boc
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Janja Ocvirk
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
eISSN:
1581-3207
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology, Radiology